Sanofi US
Cambridge
Massachusetts
United States
212 articles about Sanofi US
-
According to HBM Partners, a healthcare investing firm, out of the drugs approved over the last five years, 63 percent originated at smaller companies.
-
New survey reveals many misconceptions exist about allergies, illustrating the need for greater education
3/27/2018
Sanofi teams up with television personality Adam Savage and allergist Dr. Neeta Ogden to help dispel common allergy misconceptions with facts
-
FDA approves Toujeo® Max SoloStar®
3/27/2018
Max SoloStar holds more insulin than any other long-acting insulin pen
-
For the second time Ablynx’s anti-IL-6R Nanobody, vobarilizumab has failed to pass muster. This morning Belgium-based company said vobarilizumab did not meet primary endpoints in a Phase II dosing study for lupus patients.
-
Sanofi and Regeneron have cut deals to dramatically reduce the price of their new cholesterol drug Praluent.
-
Seven months after Prevail Therapeutics launched, the company has secured $75 million in Series A financing to support the development of gene therapies for Parkinson’s disease.
-
Esperion announced that its bempedoic acid for lowering LDL-C cholesterol had positive results in a Phase III clinical trial.
-
While the focus has been on M&A activity, Venture Capital firms have been investing billions in Biotech companies in 2018.
-
Asthma patients may soon have a new treatment option.
-
Sanofi US Collaborates With Duke University And Massachusetts General Hospital On Big Data And Type 2 Diabetes
4/28/2016
-
Sanofi US To Return Auvi-Q (epinephrine injection, USP) Rights To Kaleo
2/24/2016
-
Pozen, Inc. And Sanofi US Mutually Agree To Terminate U.S. Partnership For PA8140/PA32540
12/1/2014
-
Sanofi US Launches Authorized Generic Version Of Eloxatin® (oxaliplatin Injection)
8/12/2014
-
Sanofi-Aventis (Massachusetts) Release: Allegra(R) and Survivor Winner Danni Boatwright Want to Hear About Your "Allergy Adventures"
8/10/2011
-
Gov. Deval Patrick Meets with Sanofi-Aventis (Massachusetts), Genzyme Corporation CEOs to Discuss Job Losses
2/18/2011
-
Albany Molecular Research, Inc. Wtih Sanofi-Aventis (Massachusetts) Files Motion for Preliminary Injunction Prohibiting Dr. Reddy's Laboratories, Inc.'s from Distributing Generic Allegra-D(R) 24
3/23/2010
-
Cegedim Dendrite Announces Extension of Customer Relationship Management (CRM) Agreement with Sanofi-Aventis (Massachusetts)
3/15/2010
-
Sanofi-aventis U.S. Introduces BenzaClin(R) Carekit - Carekit Offers Acne Patients Simple and Convenient Moisturizing Option
8/4/2009
-
Antisoma PLC Sells Oral Fludarabine to Sanofi-Aventis (Massachusetts) for $65 Million
5/12/2009
-
Sanofi-Aventis (New York) And Bristol-Myers Squibb Company Release: Rationale and Design of CURRENT-OASIS 7 Study Published in American Heart Journal
11/6/2008